Scholarlink

<p>Unconjugated bilirubin (UCB) induces neurotoxicity in newborns, yet effective interventions remain limited. This study explores the neuroprotective role and mechanisms of parthenolide (PRT) using both in vivo and in vitro models. Primary rat neuronal cells exposed to UCB were evaluated through CCK-8, flow cytometry, Western blot, and immunofluorescence assays. Additionally, a rat model of bilirubin encephalopathy was established via bilirubin injection to verify PRT’s effects in vivo. The results indicated that UCB significantly suppressed autophagy, increased LDH release and apoptosis, and reduced cell viability. PRT treatment effectively attenuated UCB-induced neuronal injury by enhancing autophagic activity. Mechanistically, PRT mediated these protective effects through inhibition of the AKT/mTOR pathway. These findings demonstrate that PRT exerts notable neuroprotective properties and may serve as a promising therapeutic candidate for bilirubin encephalopathy.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Parthenolide ameliorates bilirubin-induced neuronal cell injury by mediating autophagy

  • 期刊论文

  • 发表日期：

    2026年1月27日

查看全文
  • Junling Liu,
  • Chunli Zhang,
  • Yuanyuan Hu,
  • Zong Zheng

摘要

Unconjugated bilirubin (UCB) induces neurotoxicity in newborns, yet effective interventions remain limited. This study explores the neuroprotective role and mechanisms of parthenolide (PRT) using both in vivo and in vitro models. Primary rat neuronal cells exposed to UCB were evaluated through CCK-8, flow cytometry, Western blot, and immunofluorescence assays. Additionally, a rat model of bilirubin encephalopathy was established via bilirubin injection to verify PRT’s effects in vivo. The results indicated that UCB significantly suppressed autophagy, increased LDH release and apoptosis, and reduced cell viability. PRT treatment effectively attenuated UCB-induced neuronal injury by enhancing autophagic activity. Mechanistically, PRT mediated these protective effects through inhibition of the AKT/mTOR pathway. These findings demonstrate that PRT exerts notable neuroprotective properties and may serve as a promising therapeutic candidate for bilirubin encephalopathy.